
    
      Patients with pathologically proven amyloidosis involving the peripheral nervous system will
      undergo 18-F Florbetapir PET/MR on a GE (General Electric Healthcare) SIGNA PET/MR scanner. A
      control arm comprised of patients with pathologically-confirmed non-amyloid causes of
      peripheral neuropathy will also undergo 18-F Florbetapir PET/MR scanning. all images will be
      reviewed for peripheral nerve uptake.
    
  